Literature DB >> 33188596

Barriers to international travel in inflammatory bowel disease patients.

Kristina Aluzaite1, Kay Greveson2, Shomron Ben-Horin3, Rupert Leong4, Ola Haj3, Michael Schultz1.   

Abstract

BACKGROUND: Inflammatory bowel disease poses substantial challenges to travel. We aimed to investigate inflammatory bowel diseases (IBD)-associated challenges to travel, information-seeking behaviour and associated factors.
METHODS: We collected data on patients' demographics, disease characteristics, travel barriers, information-seeking behaviour and travel outcomes in UK, Australia, New Zealand and Israel (2016-2018). Summary statistics were used to describe the sample, whereas multivariate binary and nominal logistic regression were used to model the outcome variables.
RESULTS: Almost 75.4% (1878/2491) participants' data were analysed with 71.14%, 15.4%, 11.2% and 2.1% from UK, Australia, NZ and Israel, respectively (76.3% females, 48.2% 30-49 years old 58.8% Crohn's disease). About 7.7% of study participants sought medical advice/were hospitalised while overseas. About 43.8% cancelled/changed their plans due to IBD. The most common barriers were worry about toilet facilities (76.3%), cleanliness/sanitation (50.9%) and availability of medical care (41.1%). Only 60.5% sought travel advice; the most popular information source was IBD doctor/nurse (32.6%). Almost 32.6% of study participants did not get travel insurance that covered their IBD. Those who did not receive advice or found obtaining travel insurance difficult, were less likely to obtain travel insurance (P < 0.001). Participants who travelled for work were more likely to be hospitalised/seek medical advice overseas and not obtain travel insurance.
CONCLUSIONS: We report a detailed investigation on the IBD-associated barriers while travelling abroad, common information-seeking behaviours and factors associated with worse outcomes. Importantly, patients from all the surveyed countries provided similar travel barrier and preparation habits, highlighting the consistent nature of the challenge. © International Society of Travel Medicine 2020. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Inflammatory bowel disease; quality of life; travel

Mesh:

Year:  2021        PMID: 33188596     DOI: 10.1093/jtm/taaa197

Source DB:  PubMed          Journal:  J Travel Med        ISSN: 1195-1982            Impact factor:   8.490


  2 in total

1.  Inflammatory Bowel Disease Self-Management: Exploring Adolescent Use of an Online Instagram Support Community.

Authors:  Caeli Malloy; Susan M Rawl; Wendy R Miller
Journal:  Gastroenterol Nurs       Date:  2022-07-13       Impact factor: 1.159

Review 2.  Perspectives on Subcutaneous Infliximab for Rheumatic Diseases and Inflammatory Bowel Disease: Before, During, and After the COVID-19 Era.

Authors:  Stefan Schreiber; Shomron Ben-Horin; Rieke Alten; René Westhovens; Laurent Peyrin-Biroulet; Silvio Danese; Toshifumi Hibi; Ken Takeuchi; Fernando Magro; Yoorim An; Dong-Hyeon Kim; SangWook Yoon; Walter Reinisch
Journal:  Adv Ther       Date:  2022-01-06       Impact factor: 4.070

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.